Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300067596Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in postoperative pain and perioperative pain (3 arms), sponsored by Hefei First People's Hospital. Primary endpoints: Blood stress index, Blood inflammatory response and 1 more. Planned start Jan 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300067596.